Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats

Zidovudine-loaded solid lipid nanoparticles (AZT-SLNs) and zidovudine in solution were prepared and administered in rats. The aim of this research was to study whether the bioavailability of zidovudine can be improved by AZT-SLNs perorally to rats as compared to oral administration of zidovudine. Zi...

Full description

Saved in:
Bibliographic Details
Main Authors: Shah Purvin, Parameswara Rao Vuddanda, Sanjay Kumar Singh, Achint Jain, Sanjay Singh
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Nanotechnology
Online Access:http://dx.doi.org/10.1155/2014/854018
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850225292833980416
author Shah Purvin
Parameswara Rao Vuddanda
Sanjay Kumar Singh
Achint Jain
Sanjay Singh
author_facet Shah Purvin
Parameswara Rao Vuddanda
Sanjay Kumar Singh
Achint Jain
Sanjay Singh
author_sort Shah Purvin
collection DOAJ
description Zidovudine-loaded solid lipid nanoparticles (AZT-SLNs) and zidovudine in solution were prepared and administered in rats. The aim of this research was to study whether the bioavailability of zidovudine can be improved by AZT-SLNs perorally to rats as compared to oral administration of zidovudine. Zidovudine was determined in plasma and tissues by reverse phase high performance liquid chromatography. The pharmacokinetic parameters of zidovudine were determined after peroral administration: area under curve of concentration versus time (AUC) for AZT-SLNs was 31.25% greater than AZT solution; meanwhile mean resident time (MRT) was found to be 1.83 times higher for AZT-SLNs than AZT solution. Elimination half life of zidovudine was also increased for SLN formulation. Tissue distribution pattern of zidovudine was changed in case of AZT-SLNs. AUC of zidovudine in brain and liver was found to be approximately 2.73 and 1.77 times higher in AZT-SLNs than AZT solution, respectively, indicating that AZT-SLNs could cross blood brain barrier. Distribution of zidovudine was approximately 0.95 and 0.86 times lesser in heart and kidney, respectively. It can be concluded from the study that oral administration of AZT-SLNs modifies the plasma pharmacokinetic parameters and biodistribution of zidovudine.
format Article
id doaj-art-521340b07f3945e880b91da3fa69eedb
institution OA Journals
issn 1687-9503
1687-9511
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Nanotechnology
spelling doaj-art-521340b07f3945e880b91da3fa69eedb2025-08-20T02:05:24ZengWileyJournal of Nanotechnology1687-95031687-95112014-01-01201410.1155/2014/854018854018Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in RatsShah Purvin0Parameswara Rao Vuddanda1Sanjay Kumar Singh2Achint Jain3Sanjay Singh4Department of Pharmaceutics, Indian Institute of Technology, (Banaras Hindu University), Varanasi 221005, IndiaDepartment of Pharmaceutics, Indian Institute of Technology, (Banaras Hindu University), Varanasi 221005, IndiaDepartment of Pharmaceutics, Indian Institute of Technology, (Banaras Hindu University), Varanasi 221005, IndiaDepartment of Pharmaceutics, Indian Institute of Technology, (Banaras Hindu University), Varanasi 221005, IndiaDepartment of Pharmaceutics, Indian Institute of Technology, (Banaras Hindu University), Varanasi 221005, IndiaZidovudine-loaded solid lipid nanoparticles (AZT-SLNs) and zidovudine in solution were prepared and administered in rats. The aim of this research was to study whether the bioavailability of zidovudine can be improved by AZT-SLNs perorally to rats as compared to oral administration of zidovudine. Zidovudine was determined in plasma and tissues by reverse phase high performance liquid chromatography. The pharmacokinetic parameters of zidovudine were determined after peroral administration: area under curve of concentration versus time (AUC) for AZT-SLNs was 31.25% greater than AZT solution; meanwhile mean resident time (MRT) was found to be 1.83 times higher for AZT-SLNs than AZT solution. Elimination half life of zidovudine was also increased for SLN formulation. Tissue distribution pattern of zidovudine was changed in case of AZT-SLNs. AUC of zidovudine in brain and liver was found to be approximately 2.73 and 1.77 times higher in AZT-SLNs than AZT solution, respectively, indicating that AZT-SLNs could cross blood brain barrier. Distribution of zidovudine was approximately 0.95 and 0.86 times lesser in heart and kidney, respectively. It can be concluded from the study that oral administration of AZT-SLNs modifies the plasma pharmacokinetic parameters and biodistribution of zidovudine.http://dx.doi.org/10.1155/2014/854018
spellingShingle Shah Purvin
Parameswara Rao Vuddanda
Sanjay Kumar Singh
Achint Jain
Sanjay Singh
Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats
Journal of Nanotechnology
title Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats
title_full Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats
title_fullStr Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats
title_full_unstemmed Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats
title_short Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats
title_sort pharmacokinetic and tissue distribution study of solid lipid nanoparticles of zidovudine in rats
url http://dx.doi.org/10.1155/2014/854018
work_keys_str_mv AT shahpurvin pharmacokineticandtissuedistributionstudyofsolidlipidnanoparticlesofzidovudineinrats
AT parameswararaovuddanda pharmacokineticandtissuedistributionstudyofsolidlipidnanoparticlesofzidovudineinrats
AT sanjaykumarsingh pharmacokineticandtissuedistributionstudyofsolidlipidnanoparticlesofzidovudineinrats
AT achintjain pharmacokineticandtissuedistributionstudyofsolidlipidnanoparticlesofzidovudineinrats
AT sanjaysingh pharmacokineticandtissuedistributionstudyofsolidlipidnanoparticlesofzidovudineinrats